A non-retroviral RNA virus persists in DNA form

Nature

Volumn 390, Issue 6657, 1997, Pages 298-301

  Klenerman, Paul ^a   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; ZIDOVUDINE;

ARTICLE; DNA DETERMINATION; DNA TRANSCRIPTION; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTER; GENOME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA VIRUS; VIRUS MENINGITIS;

ANIMALS; CATTLE; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA, VIRAL; DOGS; GERBILLINAE; GUINEA PIGS; HELA CELLS; HUMANS; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RATS; SPECIES SPECIFICITY; SPLEEN; VERO CELLS;

CHORIOMENINGITIS VIRUS; CRICETINAE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; RNA VIRUSES;

EID: 0030778790     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/36876     Document Type: Article

References (30)

1. Lau, L. L., Jamieson, B. D., Somasundaram, T. & Ahmed, R. Cytotoxic T-cell memory without antigen. Nature 369, 648-652 (1994).
2. Slifka, M., Matloubian, M. & Ahmed, R. Bone Marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69, 1895-1902 (1995).
3. Zinkernagel, R. M. et al. On immunological memory. A. Rev. Immunol. 14, 333-368 (1996).
4. Kundig, T. et al. On the role of antigen in maintaining CTL memory. Proc. Natl Acad. Sci. USA 93, 9716-8723 (1996).
5. Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54-60 (1996).
6. Battegay, M. et al. Quantification of LCMV with immunological focus assay in 24 or 96 well plates. J. Virol. Methods 33, 191-198 (1991).
7. Pircher, H. et al. Viral escape by selection of cytotoxic T cell-resistant variants in vivo. Nature 346, 629-233 (1990).
8. Kagi, D. et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37 (1994).
9. Smith, M., Brian, E. L. & Pagano, J. Resumption of virus production after HIV infection of T lymphocytes in the presence of AZT. J. Virol. 61, 3769-3773 (1987).
10. Rawls, W., Banerjee, S., McMillan, C. & Buchmeier, M. Inhibition of Pichinde virus replication by Actinomycin D. J. Gen. Virol. 33, 421-434 (1976).
11. Planz, O., Seiler, P., Hengartner, H. & Zinkernagel, R. Specific CTL eliminate cells producing neutralizing antibodies. Nature 382, 726-730 (1996).
12. Lehmann-Grube, F. Lymphocytic choriomeningitis virus. Virol. Monogr. 10, 28-106 (1971).
13. Pyra, H., Boeni, J. & Schupbach, J. Ultrasensitive retrovirus detection by a RT assay based on product enhancement. Proc. Natl Acad. Sci. USA 51, 1544-1548 (1994).
14. Oxenius, A. et al. Presentation of endogenous viral proteins in association with MHC Class II. Eur. J. Immunol. 25, 3402-3411 (1995).
15. Oldstone, M. & Buchmeier, M. Restricted expression of viral glycoprotein in cells of persistently infected mice. Nature 300, 360-362 (1982).
16. Lehmann-Grube, F. A carrier state of LCMV in L cell cultures. Nature 213, 770-773 (1967).
17. Moskophidis, D. & Zinkernagel, R. M. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69, 2187-2193 (1995).
18. Salvato, M. in The Arenaviridae (ed. Salvato, M.) 133-156 (Plenum, New York, 1993).
19. Heidmann, O. & Heidmann, T. Retrotransposition of a mouse IAP sequence tagged with an indicator gene. Cell 64, 159-170 (1991).
20. Zhdanov, V. Integration of viral genomes. Nature 256, 471-473 (1975).
21. Wiener, A., Deininger, P. & Efstratiadis, A. Nonretroviral transposons: Genes, pseudogenes and transposable elements generated by reverse flow of genetic information. A. Rev. Biochem. 55, 631-661 (1986).
22. Coffin, J. in Reverse Transcriptase (eds Skalka, A. & Gough, S.) 445-479 (Cold Spring Harbour Laboratory Press, New York, 1993).
23. Oldstone, M. & Dixon, F. Activation of murine leukaemia virus related antigen by LCMV. Science 174, 843-845 (1971).
24. Pease, L. & Murphy, W. Co-infection by LDV and C type retrovirus elicits neurological disease. Nature 286, 398-400 (1980).
25. + T cells, and interferons in persistent and acute infections of mice with LCMV: implications for adoptive immunotherapy of virus carriers. Proc. Natl Acad. Sci. USA 94, 6874-6879 (1997).
26. Loewer, R., Loewer, J. & Kurth, R. The viruses in all of us: Characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl Acad. Sci. USA 93, 5177-5184 (1996).
27. Yokoyama, M., Zhang, J. & Whitton, J. DNA immunization confers protection against lethal LCMV. J. Virol. 69, 2684-2688 (1995).
28. Skyulev, Y., Joo, M., Vturina, I., Tsomides, T. & Eisen, H. Evidence that a single peptide-MHC complex on a target cell can elicit a CTL response. Immunity 4, 565-571 (1996).
29. Romanowski, V., Matsuura, Y. & Bishop, D. Complete sequence of the S RNA of LCMV (WE) compared to that of Pichinde. Virus Res. 3, 101-108 (1985).
30. Silver J., Maudru, T., Fujita, K. & Repaske, R. An RT-PCR assay for the enzyme activity of reverse transcriptase capable of detecting single virions. Nucleic Acids Res. 21, 3593-3594 (1993).